Polymorphism of the dihydropteroate synthase resistance gene of Plasmodium falciparum in three hospitals in Mbouda, Western Cameroon
Tropical Diseases, Travel Medicine and Vaccines · Published 2025-11-11 · DOI 10.1186/s40794-025-00278-9
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1186/s40794-025-00278-9
Abstract
Abstract Background Malaria, is an endemic disease which causes significant mortality worldwide, particularly in Africa, including Cameroon. This study aimed to characterize the Pfdhps resistance gene of Plasmodium falciparum in three hospitals in Mbouda Cameroon. Method Two hundred and ninety-six samples were collected from consenting patients for rapid diagnostic tests (RDT) and thick blood smear (TBS) to determine parasite intensity. Positive samples were spotted on Whatman paper for molecular analysis. Plasmodial DNA was extracted using the Chelex-100 method, and amplification was performed via nested PCR. The A437G and A581G mutations were identified using restriction fragment length polymorphism (RFLP) with AvaII and BstUI enzymes, followed by 1.3% agarose gel electrophoresis. Data were analyzed using SPSS 21 software. Results The prevalence of Plasmodium falciparum was 25.34%. The Pfdhps resistance gene prevalence was 74.66%, with A437G 56% and A581G 64% mutations. the age group [6–35] are the majority carriers of the gene and females (77.8%) have a higher prevalence of the gene than males (71.8%). Mutant alleles showed higher frequencies (57.14% for A437G and 91.66% for A581G) compared to wild-type alleles (42.85% for A437G and 8.33% for A581G). The mutant alleles of the two mutations are more predominant in the age group [6–35] and in females for A437G and in males for A581G. Conclusion The Pfdhps resistance gene was prevalent in Mbouda, with high rates of A437G and A581G mutations. These findings highlight the need for enhanced epidemiological surveillance of antimalarial resistance, particularly in Mbouda.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2025
Related articles
- The global outbreak of Oropouche virus: surveillance of global trends · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Rwanda’s National Reference Laboratory Operational Capacity during the 2024 Marburg Virus Disease Outbreak Response · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Self-reported hepatitis B vaccination uptake and associated factors among adults in a tertiary hospital, Nasarawa State, Nigeria · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Clinical, laboratory features and treatment outcomes of patients infected with Fasciola in Northern Vietnam, 2019–2023 · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- The silent microbial shift: climate change amplifies pathogen evolution, microbiome dysbiosis, and antimicrobial resistance · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Safety of COVID-19 revaccination in patients with prior hypersensitivity reactions: a retrospective study · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Furuncular cutaneous myiasis after travel in South America: case report and epidemiologic, diagnostic and management considerations · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Integrated strategies for controlling and eliminating Neglected Tropical Diseases in Sub-Saharan Africa: a review of approaches, challenges, and opportunities · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Integrated assessment of malaria parasite load, anemia, and associated factors in patients with and without soil-transmitted helminthes coinfection in Southern Ethiopia · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Marburg and Sudan virus outbreaks: are we any closer to a pan-filovirus vaccine? · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal